StockData
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.11−0.03 (-19.40%)

Close on Nov 17, 2026Market cap $5.66MP/E –Yield –

AEON Biopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

AEON Biopharma's pe ratio was 0.2× on Jan 30, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 20260.2×+0.0
2025Dec 31, 20250.2×–

More AEON Biopharma figures

See a number that looks wrong?